Avinger, Inc., founded in Redwood City, US, is dedicated to innovating medical devices and surgical equipment. The company's core mission is to improve the treatment of vascular diseases through advanced imaging technology. Avinger's flagship products include the Pantheris and Lumivascular systems, which utilize real-time image-guided intervention to enhance the precision and safety of vascular procedures. Their market focus is primarily on healthcare providers in the United States, aiming to revolutionize the treatment of peripheral artery disease (PAD).
Notable figures associated with Avinger include its founder, Dr. John B. Simpson, a pioneer in interventional cardiology. The company has garnered significant attention from investors and the medical community for its groundbreaking technologies. Key achievements include FDA clearance for their next-generation OCT-guided CTO crossing system and the successful implementation of their devices in numerous clinical settings. Avinger's impact is evident in improved patient outcomes and heightened awareness of advanced treatment options for vascular diseases.